Drug profile · INN
isoproterenol sulfate
MEDIHALER-ISO
isoproterenol sulfate (MEDIHALER-ISO) is a adrenergic receptor beta agonist. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — isoproterenol sulfate
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
isoproterenol sulfate (MEDIHALER-ISO) is a adrenergic receptor beta agonist. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor beta agonist
Primary target: Adrenergic receptor beta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is isoproterenol sulfate?
isoproterenol sulfate (MEDIHALER-ISO) is a adrenergic receptor beta agonist. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for isoproterenol sulfate?
MEDIHALER-ISO is a marketed brand name for isoproterenol sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isoproterenol sulfate?
isoproterenol sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.